Transaction #459 · Form 4 · 0000919574-25-006126
SPRUCE BIOSCIENCES, INC. · Purchase · Common Stock, $0.001 par value per share
SPRUCE BIOSCIENCES, INC. · Transacted October 6, 2025 · Filed October 15, 2025
What does this filing report?
An SEC Form 4 filing for SPRUCE BIOSCIENCES, INC. records a purchase involving Common Stock, $0.001 par value per share on October 6, 2025. The reported quantity was 256. The filing date is October 15, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- SPRUCE BIOSCIENCES, INC.
- Company CIK
- 0001683553
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 256
- Reported price
- 17.9108 · See footnotes
- Reference value
- 4,585.1648
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 1,307
- Ownership description
- See footnote
- SEC acceptance time
- Oct 15, 2025, 4:32 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Parkman Healthcare Partners LLC ↗
10% owner
CIK 0001777015
- Martinez Gregory ↗
10% owner
CIK 0002091748
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $17.55 to $18. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F2
- The amount reported represents the Reporting Persons' pecuniary interest held through an investment in private funds. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F3
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $19.125 to $19.63. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $17.44 to $17.56. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks
As previously disclosed in Parkman Healthcare Partners LLC's Form 4 with respect to the Issuer filed on October 8, 2025, these securities are also indirectly beneficially owned by Gregory Martinez.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.